PME logo

Pro Medicus Limited Stock Price

ASX:PME Community·AU$17.2b Market Cap
  • 6 Narratives written by author
  • 8 Comments on narratives written by author
  • 217 Fair Values set on narratives written by author

PME Share Price Performance

AU$164.69
-148.79 (-47.46%)
AU$196.78
Fair Value
AU$164.69
-148.79 (-47.46%)
16.3% undervalued intrinsic discount
AU$196.78
Fair Value
Price AU$164.69
ZayaanS AU$196.78
AnalystLowTarget AU$233.18
AnalystConsensusTarget AU$190.74

PME Community Narratives

Fair Value
·
Fair Value AU$196.78 16.3% undervalued intrinsic discount

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

22users have liked this narrative
8users have commented on this narrative
41users have followed this narrative
·
Fair Value AU$233.18 29.4% undervalued intrinsic discount

Cloud Imaging And AI Risks Will Persist Yet Support Long Term Upside Potential

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
·
Fair Value AU$190.74 13.7% undervalued intrinsic discount

Cloud Imaging And AI Adoption Will Drive Long Term Healthcare Platform Dominance

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
AU$199.7
17.5% undervalued intrinsic discount
Fair Value
Revenue
17.32% p.a.
Profit Margin
97.56%
Future PE
59.07x
Price in 2031
AU$294.69
AU$196.78
16.3% undervalued intrinsic discount
Fair Value
Revenue
17.32% p.a.
Profit Margin
97.56%
Future PE
57.87x
Price in 2031
AU$288.69
AU$133.68
23.2% overvalued intrinsic discount
Fair Value
Revenue
-9.04% p.a.
Profit Margin
53.25%
Future PE
327.23x
Price in 2030
AU$191.26
AU$250
34.1% undervalued intrinsic discount
Revenue
32.04% p.a.
Profit Margin
57.44%
Future PE
102.54x
Price in 2029
AU$312.06
AU$190.74
13.7% undervalued intrinsic discount
Revenue
23.55% p.a.
Profit Margin
57.2%
Future PE
95.91x
Price in 2029
AU$238.12
AU$233.18
29.4% undervalued intrinsic discount
Revenue
26.01% p.a.
Profit Margin
55.36%
Future PE
129.33x
Price in 2029
AU$292.15

Updated Narratives

PME logo

A stock I’m bullish on is Pro Medicus Limited (ASX: PME), an Australian healthcare technology company that develops medical imaging software

Fair Value: AU$199.7 17.5% undervalued intrinsic discount
11 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
PME logo

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value: AU$196.78 16.3% undervalued intrinsic discount
41 users have set this as their fair value
8 users have commented on this narrative
0 users have liked this narrative
PME logo

Great Company.... but so expensive!

Fair Value: AU$133.68 23.2% overvalued intrinsic discount
22 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
2 Rewards

Pro Medicus Limited Key Details

AU$240.6m

Revenue

AU$321.0k

Cost of Revenue

AU$240.2m

Gross Profit

AU$5.6m

Other Expenses

AU$234.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 18, 2026
2.25
99.87%
97.56%
0%
View Full Analysis

About PME

Founded
1983
Employees
132
CEO
Sam Hupert
WebsiteView website
www.promed.com.au

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Recent PME News & Updates

Narrative Update Jul 24

PME: Long Term US PACS Share Assumptions Will Drive Future Upside

Analysts have trimmed their fair value estimate for Pro Medicus to A$250.00 from A$300.00, citing more cautious assumptions about the company’s long term US PACS market share, even as recent Street research points to a higher near term price target. What's in the News for Pro Medicus Pro Medicus Limited continues to build its position as a healthcare informatics company, supported by rapid organic growth, strong cash conversion and a debt free balance sheet.

Recent updates

No updates